Jane Metrik1, Samantha G Farris2, Elizabeth R Aston3, Christopher W Kahler3. 1. Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI, 02903, USA; Providence Veterans Affairs Medical Center, Providence, RI, 02908, USA; The Warren Alpert Medical School of Brown University, Department of Psychiatry and Human Behavior, Providence, RI 02906, USA. Electronic address: Jane_Metrik@Brown.edu. 2. The Warren Alpert Medical School of Brown University, Department of Psychiatry and Human Behavior, Providence, RI 02906, USA; The Miriam Hospital, Centers for Behavioral and Preventative Medicine, Providence, RI, 02906, USA; Butler Hospital, Providence, RI, 02906, USA. 3. Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI, 02903, USA.
Abstract
BACKGROUND: The present research examines anticipated consequences of ceasing or reducing marijuana use with initial development and psychometric validation of a measure of marijuana cessation expectancies. METHODS: The 46-item Marijuana Cessation Expectancies Questionnaire (MCEQ) was initially developed from the content validity analysis of free responses about expected outcomes of stopping and decreasing marijuana use generated by 94 participants. The closed-ended MCEQ was subsequently administered to 151 non-treatment seeking regular marijuana users (used on M=64.7% of the prior 60days, SD=25.1%;Mage=21.4, SD=3.96; 38.4% female). RESULTS: Exploratory factor analyses identified six MCEQ factors that accounted for 61% of variance, which were related to expected improvement in: 1) performance/motivation, 2) problems with authority, and 3) interpersonal functioning, and expected worsening of 4) mood states and 5) fun experiences, and 6) changes in appetite/weight from cessation/reduction of marijuana use. Internal consistency of full scale items was good (α=0.86) and moderate to high for all factors (α's=0.60-0.89). The MCEQ items showed good concurrent validity with key measures and incremental associations with change indices (prior history of cessation/reduction attempt, benefits of reduction, importance of change), beyond the effects of marijuana use expectancies. CONCLUSIONS: These data provide initial support for the MCEQ and suggest it is closely linked to reduction/cessation decisions in marijuana users. MCEQ may be used clinically to enhance existing behavioral treatments and motivational interventions for problem marijuana use. Published by Elsevier B.V.
BACKGROUND: The present research examines anticipated consequences of ceasing or reducing marijuana use with initial development and psychometric validation of a measure of marijuana cessation expectancies. METHODS: The 46-item Marijuana Cessation Expectancies Questionnaire (MCEQ) was initially developed from the content validity analysis of free responses about expected outcomes of stopping and decreasing marijuana use generated by 94 participants. The closed-ended MCEQ was subsequently administered to 151 non-treatment seeking regular marijuana users (used on M=64.7% of the prior 60days, SD=25.1%;Mage=21.4, SD=3.96; 38.4% female). RESULTS: Exploratory factor analyses identified six MCEQ factors that accounted for 61% of variance, which were related to expected improvement in: 1) performance/motivation, 2) problems with authority, and 3) interpersonal functioning, and expected worsening of 4) mood states and 5) fun experiences, and 6) changes in appetite/weight from cessation/reduction of marijuana use. Internal consistency of full scale items was good (α=0.86) and moderate to high for all factors (α's=0.60-0.89). The MCEQ items showed good concurrent validity with key measures and incremental associations with change indices (prior history of cessation/reduction attempt, benefits of reduction, importance of change), beyond the effects of marijuana use expectancies. CONCLUSIONS: These data provide initial support for the MCEQ and suggest it is closely linked to reduction/cessation decisions in marijuana users. MCEQ may be used clinically to enhance existing behavioral treatments and motivational interventions for problem marijuana use. Published by Elsevier B.V.
Authors: Peter M Monti; Suzanne M Colby; Nadine R Mastroleo; Nancy P Barnett; Chad J Gwaltney; Timothy R Apodaca; Damaris J Rohsenow; Molly Magill; Aruna Gogineni; Michael J Mello; Walter L Biffl; William G Cioffi Journal: J Consult Clin Psychol Date: 2014-08-11
Authors: Jane Metrik; Christopher W Kahler; Brady Reynolds; John E McGeary; Peter M Monti; Margaret Haney; Harriet de Wit; Damaris J Rohsenow Journal: Psychopharmacology (Berl) Date: 2012-05-16 Impact factor: 4.530
Authors: Mary Beth Miller; Ryan W Carpenter; Lindsey K Freeman; Ashley F Curtis; Ali M Yurasek; Christina S McCrae Journal: J Clin Sleep Med Date: 2022-04-01 Impact factor: 4.062